Vimta Labs Ltd (VIMTALABS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 179255, "name": "Vimta Labs", "stock_name": "Vimta Labs", "full_name": "Vimta Labs Ltd", "name_url": "stocks-analysis/vimta-labs", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "422.40", "chg": -9.6, "chgp": "-2.22%", "dir": -1, "prev_price": "432.00", "mcapval": "1,901.00 Cr", "mcap": "Small Cap", "scripcode": 524394, "symbol": "VIMTALABS", "ind_name": "Healthcare Services", "ind_code": 26, "indexname": "", "isin": "INE579C01029", "curr_date": "Feb 06", "curr_time": "", "bse_nse_vol": "1.61 lacs", "exc_status": "Active", "traded_date": "Feb 06, 2026", "traded_date_str": "2026 02 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vimta-labs-179255-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Vimta Labs Gains 3.33%: 2 Key Factors Driving This Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-gains-333-2-key-factors-driving-this-weeks-volatility-3827468", "imagepath": "", "date": "2026-02-08 14:01:10", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Strong gap up opens week at Rs.434.60 (+5.65%)</p>\n <p><strong>3 Feb:</strong> Intraday high of Rs.464.35, closes at Rs.438.15 (+0.82%)</p>\n <p><strong>5 Feb:</strong> Valuation concerns emerge as stock dips 3.63% to Rs.432.00</p>\n <p><strong>6 Feb:</strong> Week closes at Rs.425.05 (-1.61%) amid cautious sentiment</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.411.35</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-val..." }, { "title": "Vimta Labs Ltd Valuation Shifts Signal Price Attractiveness Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-valuation-shifts-signal-price-attractiveness-challenges-3821486", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VimtaLabsLtd_valuationdot_3821486.png", "date": "2026-02-05 08:00:12", "description": "Vimta Labs Ltd, a prominent player in the healthcare services sector, has witnessed a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a diminished price attractiveness despite the company’s robust operational performance and long-term returns that have outpaced the broader market." }, { "title": "Vimta Labs Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3818399", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VimtaLabsLtd_gapup_3818399.png", "date": "2026-02-03 11:06:02", "description": "Vimta Labs Ltd witnessed a significant gap up at market open on 3 Feb 2026, surging by 6.85% to touch an intraday high of Rs 464.35. This strong start reflects positive sentiment within the healthcare services sector despite the stock’s recent underperformance relative to broader benchmarks." }, { "title": "Vimta Labs Falls 19.71%: 6 Key Factors Driving the Sharp Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-falls-1971-6-key-factors-driving-the-sharp-weekly-decline-3814724", "imagepath": "", "date": "2026-02-01 14:01:16", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jan:</strong> Death Cross formation signals bearish trend</p>\n <p><strong>27 Jan:</strong> Technical momentum shifts amid market volatility</p>\n <p><strong>28 Jan:</strong> Intraday low hit amid price pressure</p>\n <p><strong>28 Jan:</strong> Q3 FY26 results reveal strong profit surge but valuation concerns</p>\n <p><strong>29 Jan:</strong> Intraday low and continued price pressure</p>\n <p><strong>29 Jan:</strong> Flat quarterly performance amid margin pressures reported</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div ..." }, { "title": "Vimta Labs Ltd Hits Intraday High with 9.24% Surge on 1 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-hits-intraday-high-with-924-surge-on-1-feb-2026-3814509", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VimtaLabsLtd_priceRelatedfactors_3814509.png", "date": "2026-02-01 11:31:22", "description": "Vimta Labs Ltd recorded a robust intraday performance on 1 Feb 2026, surging 9.24% to touch a day’s high of Rs 462.4, marking a significant rebound after five consecutive days of decline. The stock outperformed its healthcare services sector peers and the broader market, reflecting heightened trading activity and volatility." }, { "title": "Vimta Labs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/vimta-labs-ltd-is-rated-sell-3811202", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VimtaLabsLtd_mojoScore_3811202.png", "date": "2026-01-30 10:10:03", "description": "Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 29 Jan 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-hits-intraday-low-amid-price-pressure-on-29-jan-2026-3809787", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VimtaLabsLtd_priceRelatedfactors_3809787.png", "date": "2026-01-29 14:17:23", "description": "Vimta Labs Ltd experienced a significant intraday decline, touching a low of Rs 423.55, reflecting a sharp 7.43% drop amid persistent selling pressure and subdued market sentiment. The stock underperformed its sector and broader indices, continuing a multi-day downward trend." }, { "title": "Vimta Labs Ltd Reports Flat Quarterly Performance Amid Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-reports-flat-quarterly-performance-amid-margin-pressures-3808581", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VimtaLabsLtd_fintrenddot_3808581.png", "date": "2026-01-29 08:00:08", "description": "Vimta Labs Ltd, a key player in the Healthcare Services sector, has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. Despite record-high cash reserves and PBDIT, the company’s earnings per share have declined to their lowest quarterly level, prompting a downgrade in its Mojo Grade from Hold to Sell." }, { "title": "Are Vimta Labs Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-vimta-labs-ltd-latest-results-good-or-bad-3808225", "imagepath": "", "date": "2026-01-28 19:15:53", "description": "Vimta Labs Ltd's latest financial results for Q3 FY26 reveal a significant year-on-year growth in consolidated net profit, which reached ₹21.50 crores, reflecting a notable increase compared to the previous year. Revenue for the same quarter was reported at ₹89.92 crores, marking a robust year-on-year growth of 20.57%. The operating margin, excluding other income, improved to 36.79%, indicating effective cost management and operational efficiency.\n\nThe company demonstrated strong operational performance, with the operating profit before depreciation, interest, and tax rising to ₹33.08 crores, showcasing a substantial margin expansion of 479 basis points from the prior year. This operational leverage is further underscored by the return on equity, which stood at 17.82% for the latest financial year, highlighting effective capital utilization.\n\nHowever, the standalone results for the quarter ended December 20..." } ], "total": 5775, "sid": "179255", "stock_news_url": "https://www.marketsmojo.com/news/vimta-labs-179255" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "03-Feb-2026", "details": "Transcript - Q3 FY 2025-26 - Investor Call Held on 28th January 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "29-Jan-2026", "details": "Newspaper Publication - Unaudited Financial Results of Q3 FY 2025-26.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "28-Jan-2026", "details": "Q3 FY 2025-26 Press Release - Unaudited Financial Results - 31st December 2025.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Vimta Labs Ltd has declared <strong>100%</strong> dividend, ex-date: 30 May 25", "dt": "2025-05-30", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Vimta Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 24 Feb 06", "dt": "2006-02-24", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Vimta Labs Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 13 Jun 25", "dt": "2025-06-13", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Strong gap up opens week at Rs.434.60 (+5.65%)

3 Feb: Intraday high of Rs.464.35, closes at Rs.438.15 (+0.82%)

5 Feb: Valuation concerns emerge as stock dips 3.63% to Rs.432.00

6 Feb: Week closes at Rs.425.05 (-1.61%) amid cautious sentiment

Week Open

Rs.411.35

Week Close

Read full news article

Vimta Labs Ltd Valuation Shifts Signal Price Attractiveness Challenges

2026-02-05 08:00:12

Vimta Labs Ltd, a prominent player in the healthcare services sector, has witnessed a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a diminished price attractiveness despite the company’s robust operational performance and long-term returns that have outpaced the broader market.

Read full news article

Vimta Labs Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 11:06:02

Vimta Labs Ltd witnessed a significant gap up at market open on 3 Feb 2026, surging by 6.85% to touch an intraday high of Rs 464.35. This strong start reflects positive sentiment within the healthcare services sector despite the stock’s recent underperformance relative to broader benchmarks.

Read full news article

Vimta Labs Falls 19.71%: 6 Key Factors Driving the Sharp Weekly Decline

2026-02-01 14:01:16

Key Events This Week

27 Jan: Death Cross formation signals bearish trend

27 Jan: Technical momentum shifts amid market volatility

28 Jan: Intraday low hit amid price pressure

28 Jan: Q3 FY26 results reveal strong profit surge but valuation concerns

29 Jan: Intraday low and continued price pressure

29 Jan: Flat quarterly performance amid margin pressures reported

Read full news article

Vimta Labs Ltd Hits Intraday High with 9.24% Surge on 1 Feb 2026

2026-02-01 11:31:22

Vimta Labs Ltd recorded a robust intraday performance on 1 Feb 2026, surging 9.24% to touch a day’s high of Rs 462.4, marking a significant rebound after five consecutive days of decline. The stock outperformed its healthcare services sector peers and the broader market, reflecting heightened trading activity and volatility.

Read full news article

Vimta Labs Ltd is Rated Sell

2026-01-30 10:10:03

Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 29 Jan 2026

2026-01-29 14:17:23

Vimta Labs Ltd experienced a significant intraday decline, touching a low of Rs 423.55, reflecting a sharp 7.43% drop amid persistent selling pressure and subdued market sentiment. The stock underperformed its sector and broader indices, continuing a multi-day downward trend.

Read full news article

Vimta Labs Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-01-29 08:00:08

Vimta Labs Ltd, a key player in the Healthcare Services sector, has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. Despite record-high cash reserves and PBDIT, the company’s earnings per share have declined to their lowest quarterly level, prompting a downgrade in its Mojo Grade from Hold to Sell.

Read full news article

Are Vimta Labs Ltd latest results good or bad?

2026-01-28 19:15:53

Vimta Labs Ltd's latest financial results for Q3 FY26 reveal a significant year-on-year growth in consolidated net profit, which reached ₹21.50 crores, reflecting a notable increase compared to the previous year. Revenue for the same quarter was reported at ₹89.92 crores, marking a robust year-on-year growth of 20.57%. The operating margin, excluding other income, improved to 36.79%, indicating effective cost management and operational efficiency. The company demonstrated strong operational performance, with the operating profit before depreciation, interest, and tax rising to ₹33.08 crores, showcasing a substantial margin expansion of 479 basis points from the prior year. This operational leverage is further underscored by the return on equity, which stood at 17.82% for the latest financial year, highlighting effective capital utilization. However, the standalone results for the quarter ended December 20...

Read full news article

View All News